Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 375

1.

Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.

Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF.

J Clin Oncol. 2005 Oct 20;23(30):7604-13. Epub 2005 Sep 26. Review.

PMID:
16186595
[PubMed - indexed for MEDLINE]
2.

Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women.

Clarke CA, Glaser SL, Dorfman RF, Mann R, DiGiuseppe JA, Prehn AW, Ambinder RF.

Cancer. 2001 Apr 15;91(8):1579-87.

PMID:
11301409
[PubMed - indexed for MEDLINE]
3.

Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.

Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S.

Mod Pathol. 2003 Jun;16(6):566-73.

PMID:
12808062
[PubMed - indexed for MEDLINE]
Free Article
4.

Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.

Diepstra A, van Imhoff GW, Schaapveld M, Karim-Kos H, van den Berg A, Vellenga E, Poppema S.

J Clin Oncol. 2009 Aug 10;27(23):3815-21. doi: 10.1200/JCO.2008.20.5138. Epub 2009 May 26.

PMID:
19470931
[PubMed - indexed for MEDLINE]
5.

Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.

Koh YW, Yoon DH, Suh C, Huh J.

Ann Hematol. 2012 Sep;91(9):1403-12. doi: 10.1007/s00277-012-1464-8. Epub 2012 Apr 18.

PMID:
22526365
[PubMed - indexed for MEDLINE]
6.

Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.

Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, Dorfman RF, Mann RB, Ambinder RF.

Cancer. 2003 Jul 15;98(2):300-9.

PMID:
12872349
[PubMed - indexed for MEDLINE]
Free Article
7.

The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.

Kwon JM, Park YH, Kang JH, Kim K, Ko YH, Ryoo BY, Lee SS, Lee SI, Koo HH, Kim WS.

Ann Hematol. 2006 Jul;85(7):463-8. Epub 2006 Mar 14.

PMID:
16534596
[PubMed - indexed for MEDLINE]
8.

Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.

Glavina-Durdov M, Jakic-Razumovic J, Capkun V, Murray P.

Br J Cancer. 2001 May 4;84(9):1227-34.

PMID:
11336475
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.

Claviez A, Tiemann M, Lüders H, Krams M, Parwaresch R, Schellong G, Dörffel W.

J Clin Oncol. 2005 Jun 20;23(18):4048-56.

PMID:
15961758
[PubMed - indexed for MEDLINE]
10.

Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study.

Jarrett RF, Stark GL, White J, Angus B, Alexander FE, Krajewski AS, Freeland J, Taylor GM, Taylor PR; Scotland and Newcastle Epidemiology of Hodgkin Disease Study Group.

Blood. 2005 Oct 1;106(7):2444-51. Epub 2005 Jun 7.

PMID:
15941916
[PubMed - indexed for MEDLINE]
Free Article
11.

The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease.

Flavell KJ, Billingham LJ, Biddulph JP, Gray L, Flavell JR, Constandinou CM, Young LS, Murray PG.

Ann Oncol. 2003 Feb;14(2):282-90.

PMID:
12562657
[PubMed - indexed for MEDLINE]
Free Article
12.

Exposure to childhood infections and risk of Epstein-Barr virus--defined Hodgkin's lymphoma in women.

Glaser SL, Keegan TH, Clarke CA, Trinh M, Dorfman RF, Mann RB, DiGiuseppe JA, Ambinder RF.

Int J Cancer. 2005 Jul 1;115(4):599-605.

PMID:
15700307
[PubMed - indexed for MEDLINE]
13.

Epstein-Barr virus expression in Hodgkin's lymphoma in Kuwait.

Makar RR, Saji T, Junaid TA.

Pathol Oncol Res. 2003;9(3):159-65. Epub 2003 Oct 7.

PMID:
14530808
[PubMed - indexed for MEDLINE]
Free Article
14.

[Association of Hodgkin lymphoma with Epstein-Barr virus in Hungary].

Keresztes K, Bessenyei B, Szöllosi Z, Beck Z, Miltényi Z, Nemes Z, Oláh E, Illés A.

Orv Hetil. 2005 Jul 24;146(30):1575-82. Hungarian.

PMID:
16136734
[PubMed - indexed for MEDLINE]
15.

A comparison of epidemiologic, histologic, and virologic studies on Hodgkin's disease in western Kenya and Nagasaki, Japan.

Kusuda M, Toriyama K, Kamidigo NO, Itakura H.

Am J Trop Med Hyg. 1998 Nov;59(5):801-7.

PMID:
9840602
[PubMed - indexed for MEDLINE]
Free Article
16.

Association of Hodgkin's lymphoma with Epstein Barr virus infection.

Cickusić E, Mustedanagić-Mujanović J, Iljazović E, Karasalihović Z, Skaljić I.

Bosn J Basic Med Sci. 2007 Feb;7(1):58-65.

PMID:
17489771
[PubMed - indexed for MEDLINE]
17.
18.

Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.

Spacek M, Hubacek P, Markova J, Zajac M, Vernerova Z, Kamaradova K, Stuchly J, Kozak T.

APMIS. 2011 Jan;119(1):10-6. doi: 10.1111/j.1600-0463.2010.02685.x. Epub 2010 Oct 25.

PMID:
21143522
[PubMed - indexed for MEDLINE]
19.

Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.

Chang ET, Zheng T, Lennette ET, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE.

J Infect Dis. 2004 Jun 15;189(12):2271-81. Epub 2004 May 21.

PMID:
15181575
[PubMed - indexed for MEDLINE]
Free Article
20.

Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in Brazil.

Souza EM, Baiocchi OC, Zanichelli MA, Alves AC, Assis MG, Eiras DP, Dobo C, Oliveira JS.

Hematol Oncol. 2010 Sep;28(3):137-41. doi: 10.1002/hon.933.

PMID:
20128016
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk